Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Wockhardt Group
Wockhardt Group
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
Wockhardt becomes India's first to get regulatory nod for novel antibiotics
The Mumbai-based drugmaker prepares to launch EMROK in the domestic market
Infection Control
Wockhardt sets up manufacturing and R&D plant in Dubai
India's biotech and pharma company has built a 10,000 sqm facility for the production and packaging of sterile dry powder injection
Regulatory
Several large Indian pharma companies under US FDA scrutiny
Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
Regulatory
US FDA to continue to target non-compliant Indian companies
All available enforcement tools to be utilised to bring facilities to compliance to ensure the protection of public health
Finance
Indian Big Pharma companies buck the global economic trend
India\'s top 25 pharma companies continue to go from strength to strength
Pharmaceutical
Indian manufacturers set to cash in on US generics market
Indian pharma companies are well positioned to generate strong revenues from the US generics market
Regulatory
Intellectual property battles rage on
Spate of cases filed recently shows that patent battles are heating up
Subscribe now